Welcome to our dedicated page for Fmc news (Ticker: FMC), a resource for investors and traders seeking the latest updates and insights on Fmc stock.
FMC Corporation reports news on its global agricultural sciences business, including crop protection solutions, biologicals, crop nutrition, digital and precision agriculture, and research into herbicide, insecticide and fungicide active ingredients. Company updates commonly cover quarterly results, outlook commentary, dividend declarations, executive conference appearances, and regulatory approvals for products such as Isoflex® active.
FMC news also reflects the operating issues of a crop protection supplier, including regional revenue trends, product commercialization, operational priorities, capital-structure matters, and governance developments affecting its board and incentive plans.
FMC (NYSE:FMC) reported Q2 2026 revenue of $867 million, down 17% year over year; revenue excluding India was $841 million, down 20%. Organic revenue declined 22%. The company posted a GAAP net loss of $187 million (–$1.49 per share) and Adjusted EBITDA of $153 million, down 26%, with adjusted EPS of $0.26, down 62%.
GAAP cash from operations rose to $363 million and free cash flow to $357 million, helped by a $200 million rimisoxafen licensing upfront. FMC outlined about $1 billion of planned proceeds for debt reduction and lowered 2026 guidance: revenue to $3.50–$3.70 billion, Adjusted EBITDA to $620–$680 million, and adjusted EPS to $1.19–$1.49. The board concluded its strategic review and the company expects year-over-year growth to resume in Q4 2026.
FMC (NYSE: FMC) announced that its board of directors has declared a regular quarterly dividend of $0.08 per share. The dividend is payable on October 15, 2026 to shareholders of record at the close of business on September 30, 2026.
FMC (NYSE:FMC) has filed the first global regulatory submission for its new herbicide active ingredient rimisoxafen with the U.S. EPA. The dossier seeks approval for use on corn, soybean, sunflower and select pulse crops.
Rimisoxafen, discovered at FMC's Stine Research Center, is the first herbicide ever classified by HRAC as a dual mode of action active (Groups 12 and 32), inhibiting two weed biochemical pathways to help delay resistance. Extensive testing shows activity against troublesome weeds Palmer amaranth and waterhemp. This is FMC's third novel herbicide advanced to regulatory submission in recent years. Rimisoxafen is not yet registered or permitted for sale or use in any country.
FMC (NYSE:FMC) agreed to a $400 million strategic minority equity investment from Tessenderlo Group at $13.30 per share, giving Tessenderlo about 20% ownership. FMC plans to use proceeds toward its approximately $1 billion debt paydown target and has concluded its strategic options review.
Recent actions include a $1.2 billion secured high-yield bond, a $252 million sale of its India commercial business, a $200 million strategic supply and license agreement prepayment with Corteva, and a $114 million Newark sale-leaseback framework.
FMC (NYSE:FMC) entered a framework agreement to sell its Newark, Delaware property for about $114 million, with a planned leaseback of active facilities. Proceeds are intended for debt reduction while retaining core R&D operations at the Stine Research Center. Closing is targeted for Q4 2026 but is not assured.
FMC (NYSE:FMC) will release its second quarter 2026 earnings on Wednesday, July 29, 2026, after the market close on its investor website and via PR Newswire.
The company will host a public webcast conference call on Thursday, July 30, 2026, at 9:00 a.m. ET.
FMC (NYSE:FMC) and Corteva announced a co-exclusive strategic supply and license agreement for rimisoxafen, covering corn and soybean markets in North and South America through the next decade.
FMC keeps ownership, supplies the active ingredient, receives a $200 million prepurchase payment, and targets first sales by decade-end, pending approvals.
FMC (NYSE:FMC) announced that chairman, CEO and president Pierre Brondeau and executive vice president and CFO Andrew Sandifer will speak at the Wolfe Research 3rd Annual Materials of the Future conference.
The presentation is scheduled for June 17, 2026 at 9:15 a.m. ET, with a live webcast at FMC's investor website.
FMC (NYSE:FMC) announced that executive vice president and CFO Andrew Sandifer will speak at the 16th Annual Wells Fargo Industrials & Materials Conference on June 9, 2026 at 2:15 p.m. Central Time. A live webcast will be accessible via FMC's investor website.
FMC (NYSE:FMC) announced that chairman, CEO and president Pierre Brondeau and executive vice president and CFO Andrew Sandifer will speak at the BMO Global Farm to Market Chemicals Conference on May 14, 2026, at 1:15 p.m. Eastern Time. A live webcast will be available on FMC's investor website.